BIOMERICA, INC. (BMRA) Total liabilities 2017–2026
BIOMERICA, INC. (BMRA) total liabilities at each fiscal year-end, per SEC filings.
$4.1MFY2026 · since FY2017: $528,866 → $4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $4.1M | +124.4% |
| FY2025 | $1.8M | -30.9% |
| FY2024 | $2.7M | -2.5% |
| FY2023 | $2.7M | -10.5% |
| FY2022 | $3.0M | +17.6% |
| FY2021 | $2.6M | -14.9% |
| FY2020 | $3.0M | +141.0% |
| FY2019 | $1.3M | +41.0% |
| FY2018 | $896,808 | +69.6% |
| FY2017 | $528,866 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BMRA financial trends
BMRA RevenueBMRA Net incomeBMRA Net marginBMRA Gross profitBMRA Gross marginBMRA Operating incomeBMRA Operating marginBMRA Operating cash flowBMRA Free cash flowBMRA Capital expendituresBMRA Return on equityBMRA Stock buybacksBMRA Dividends paidBMRA Total assetsBMRA Shareholders’ equityBMRA overview →